Partial agonists at the glycine modulatory site of the nmda...

Details Partial agonists at the glycine modulatory site of the nmda... Partial agonists at the glycine modulatory site of the nmda...

A - Human Necessities

61

K

A61K 31/42 (2006.01) A61K 31/00 (2006.01) A61K 31/195 (2006.01) A61K 31/198 (2006.01) A61K 38/52 (2006.01) A61K 45/06 (2006.01)

Patent

CA 2414171

The present invention involves the use of partial glycine agonists directed at the glycine modulatory site of the MNDA receptor to treat cognitive dysfunction in mammals with Parkinson's disease or schizophrenia.

L'invention concerne l'utilisation d'agonistes de glycine partiels dirigés sur le site modulateur de la glycine du récepteur MNDA, en vue de traiter les dysfonctionnements cognitifs, affectant les mammifères, causés par la maladie de Parkinson ou la schizophrénie.

Affiliated with

Also associated with

Rating

Partial agonists at the glycine modulatory site of the nmda... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Partial agonists at the glycine modulatory site of the nmda..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Partial agonists at the glycine modulatory site of the nmda... will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-2035860